The IOpener® is a blood-based diagnostic test that supports immunotherapy treatment selection. This peptide microarray-based test measures the activity of kinases in peripheral blood mononuclear cell isolated from a single tube of blood from a patient to determine the likelihood of responding to immunotherapy. The IOpener™ test is currently available as in-house developed test and is in the final phase of clinical validation for CE-IVD certification.